PRKCE has been proven to be a critical DEG in NAFLD, and the expression level and DNA methylation of PRKCE and IGFBP2 were altered in obesity-derived NAFLD [26]. Here, IGFBP2 is linked to metabolic dysfunction-associated steatotic liver disease.